Cervical cancer in the Omsk Region: epidemiological aspects

Klinyshkova T.V., Turchaninov D.V., Buyan M.S.

1 Omsk State Medical University, Ministry of Health of Russia, Omsk 644043, Lenina str. 12, Russia; 2 City Polyclinic Eight, Omsk 644052, Bagrationa str. 10, Russia
Objective. To assess the epidemiological situation of cervical cancer (CC) among the female population in the Omsk Region in 2002–2016.
Subjects and methods. Intensive and extensive indicators and their standard errors were calculated in the descriptive observational retrospective epidemiological study. The dynamic series of indicators were analyzed with alignment using the least squares method and with calculation of growth (decrease) rates (Rinc/dec in %), that characterized the long-term epidemic trend. The official statistical data of the Russian Federal State Statistics Service on population size by sex and age were used for calculations.
Results. In the period 2002-2016, the incidence of CC in the Omsk Region was stable and averaged 19.63±0.360/0000 (Rinc = +0.05; p> 0.05); that in the Russian Federation (RF) did 18.46±0.040/0000 and was considerably lower (p < 0.01); moreover, there was a moderate, statistically significant tendency to increase this indicator (Rinc = +1.72; p < 0.001). The analysis of the CC neglect index in the RF showed the stability of the situation; this indicator in the Omsk Region had a moderate positive tendency to decrease from 52.7% in 2001 to 40.6% in 2016;
p < 0.001). The average annual rate for the region was 46.7±0.88%, which was 1.2 times higher than the federal rate (38.1±0.11%; p < 0.001). In 2013–2016, the cytologic screening coverage of public health care facilities in the Omsk Region was 31.9 to 36.7%. The maximum incidence of CC was observed in the age group of 55–59 years (37.41±1.46), its moderate growth rate was traced in the age groups of 20–24 years (Rinc = +3.3%) and 70–74 years (Rinc = +4.1%). The study of the age structure in patients with CC established that 50–54-year-old women constituted the largest proportion in both the Omsk Region (13.0%) and the RF (12.8%).
Conclusion. The incidence of CC in the female population of the Omsk Region was stable over 15 years (2002–2016), while the RF showed a moderate significant trend towards increasing this rate. The Region displayed a tendency to reduce the CC neglect index during the period of analysis from 52.7 to 40.6% (p < 0.001); however, but the average annual rate exceeded the similar federal rate by 1.2 times. Women aged 50–54 years were prevalent cases of CC. Rejuvenation of the latter is confirmed by the disease growth rates in the age group of 20–24 years in the Omsk Region and the RF. The insufficient effectiveness of opportunistic cytological screening in the public healthcare system, which negatively affects CC morbidity rates and neglect index in the Omsk Region.

Keywords

cervical cancer
morbidity
neglect
age
cytological screening
epidemiological study
Omsk Region

Supplementary Materials

  1. Table 1 - The incidence of female genital cancer incidence in the Omsk region and the Russian Federation (2001-2016, per 100,000 female population)
  2. Table 2 - Indices of the incidence of cervical cancer in the Omsk region and the Russian Federation (2001-2016, per 100,000 female population)
  3. Figure 1 - The indicator of neglect of cervical cancer in the Russian Federation and, % (95% confidence interval)
  4. Figure 2 - Age-specific rates of cervical cancer incidence in the female population aged 15 years and over in the Russian Federation and the Omsk Region (per 100,000 women of the corresponding age group, 95% confidence interval)

References

1. Прилепская В.Н., Назарова Н.М., Суламанидзе Л.А., Бурменская О.В., Трофимов Д.Ю., Павлович С.В. Заболевания аногенитальной области, ассоциированные с папилломавирусной инфекцией. Гинекология. 2015; 17(1): 4-7. [Prilepskaya V.N., Nazarova N.M., Sulamanidze L.A., Burmenskaya O.V., Trofimov D.Yu., Pavlovich S.V. Diseases of the anogenital area associated with papillomavirus infection. Ginekologiya/Gynecology. 2015; 1: 4–7. (in Russian)]

2. Каприн А.Д., Старинский В.В., Петрова Г.В., Грецова О.П., Александрова Л.М. Злокачественные новообразования женских половых органов в России: ситуация и проблемы. Архив акушерства и гинекологии им. В.Ф. Снегирева. 2014; 1(2): 44-7. [Kaprin A.D., Starinskii V.V., Petrova G.V., Gretsova O.P., Aleksandrova L.M. Malignant neoplasms of female genitalia in Russia: situation and problems. Arhiv akusherstva i ginekologii im. V.F. Snegireva/Archive of Obstetrics and Gynecology im. V.F. Snegireva. 2014; 1(2): 44—47. (in Russian)]

3. Клинышкова Т.В., Турчанинов Д.В., Самосудова И.Б. Эпидемиологические аспекты цервикального предрака у женского населения г. Омска (по материалам выборочного исследования). Российский вестник акушера-гинеколога. 2013; 13(4): 13-7. [Klinyshkova T.V., Turchaninov D.V., Samosudova I.B. Epidemiological aspects of cervical precancer in the female population of Omsk (based on a sample study). Ross. vestnik akushera-ginekologa/Russian bulletin of an obstetrician-gynecologist.2013; 4:13-17. (in Russian)]

4. Международное агентство по изучению рака. Available at: http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp [International Agency for the Study of Cancer. Available at: http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp (in Russian)]

5. Wentzensen N., Arbyn M., Berkhof J., Bower M., Canfell K., Einstein M. et al. Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice. Int. J. Cancer. 2017; 140(10): 2192-200.

6. De Sanjose S. MTC 01-02: The state of the art of HPV epidemiology, cervical vs oral. In: Eurogin 2016: Abstracts. Part 1 – Main conference program: 4-5.

7. Clifford G., Franceschi S., Plummer M., De Martel C. The burden of HPV associated cancers in men and women. In: Eurogin 2016: Abstracts. Part 1 – Main conference program: 2-3.

8. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2012 году (заболеваемость и смертность). М.: ФГБУ «МНИОИ им. П.А.Герцена» Минздрава России; 2014. 250с. [Kaprin A.D., Starinsky V.V., Petrova G.V., ed. Malignant neoplasms in Russia in 2012 (morbidity and mortality). Moscow: FGBU “MNIOI im. P.A. Herzen” of the Ministry of Health of Russia; 2014. 250p. (in Russian)]

9. Дисая Ф.Дж., Крисман У.Т., ред. Клиническая онкогинекология. т.1. Рид Элсивер; 2012. 316с. [Disaya F.J., Krisman U.T., ed. Clinical oncogynecology. vol.1. Reed Elsevier; 2012. 316p. (in Russian)]

10. Михетько А.А. Рак шейки матки в республике Карелия. Эпидемиология и скрининг. Вопросы онкологии. 2010; 56(6): 660-3. [Mikhet’ko A.A. Cervical cancer in the Republic of Karelia. Epidemiology and Screening. Voprosy onkologii/Questions of oncology. 2010; 56(6): 660-3. (in Russian)]

11. Егорова А.Т., Свирская С.В. Состояние заболеваемости раком шейки матки женщин в Красноярском крае. Сибирский медицинский журнал. (Иркутск). 2011; 106(7): 90-3. [Egorova A.T., Svirska S.V. The incidence of cervical cancer in women in the Krasnoyarsk Territory. Sibirskij medicinskij zhurnal/Siberian Medical Journal. 2011; (7): 90-3. (in Russian)]

12. Марочко К.В., Артымук Н.В., Фетисова Т.И. Проблемы диагностики рака шейки матки в Кемеровской области. Мать и дитя в Кузбассе. 2015; 4: 31-5. [Marochko K.V., Artymuk N.V., Fetisova T.I. Problems of diagnosis of cervical cancer in the Kemerovo region. Mat’ i ditja v Kuzbasse/Mother and child in Kuzbass.2015; (4): 31-35. (in Russian)]

13. Эйхман В.О., Сафьянова Т.В., Широкоступ С.В. Эпидемиология и вакцинопрофилактика рака шейки матки в Алтайском крае. Медицинский альманах. 2014; 4: 87-9. [Eikhman V.O., Saf’yanova T.V., Shirokostup S.V. Epidemiology and vaccine prophylaxis for cervical cancer in the Altai Territory. Medicinskij al’manah/Medical almanac. 2014; (4): 87-9. (in Russian)]

14. Гордиенко В.П., Леонтьева С.Н., Константинова М.Ю., Мажарова О.А. Злокачественные новообразования репродуктивных органов у женщин Амурской области. Дальневосточный медицинский журнал. 2016; 4: 47-53. [Gordienko V.P., Leont’eva S.N., Konstantinova M.Yu., Mazharova O.A. Malignant neoplasms of reproductive organs in women of the Amur Region. Dal’nevostochnyj medicinskij zhurnal/Far Eastern Medical Journal.2016; (4); 47-53. (in Russian)]

15. Писарева Л.Ф., Бояркина А.П., Одинцова И.Н., Гурина Л.И., Волков М.В. Рак женских репродуктивных органов. Тенденции заболеваемости в Приморском крае (1992-2011гг.). Акушерство и гинекология. 2013; 9: 84-9. [Pisareva L.F., Boyarkina A.P., Odintsova I.N., Gurina L.I., Volkov M.V. Female reproductive organ cancer: morbidity trends in the Primorye Territory (1992—2011). Akusherstvo i ginekologiya/Obstetrics and gynecology. 2013; (9); 84-9. (in Russian)]

16. Голева О.П., Тасова З.Б., Прудникова О.Н., Леонов О.В., Ширинская Н.В. О проблеме своевременности выявления злокачественных новообразований шейки матки в Омской области. Здравоохранение Российской Федерации. 2016; 60(6): 298-302. [Goleva O.P., Tasova Z.B., Prudnikova O.N., Leonov O.V., Shirinskaya N.V. On the problem of timely detection of malignant neoplasms of the cervix in the Omsk region. Zdravoohranenie Rossijskoj Federacii/Health care of the Russian Federation. 2016; 60(6); 298-302. (in Russian)]

17. Смирнова Т.Л., Игонин Ю.А. Анализ запущенных случаев рака шейки матки в Чувашской республике. Международный научно-исследовательский журнал. 2017; 4-3: 184-6. [Smirnova T.L., Igonin Yu.A. Analysis of advanced cases of cervical cancer in the Chuvash Republic. Mezhdunarodnyj nauchno-issledovatel’skij zhurnal/International Scientific and Research Journal. 2017; 4(58): 184-6. (in Russian)]

18. Курунова И.И., Боровская Т.Ф., Марочко А.Ю., Бессмертная Н.Г. Эпидемиологические аспекты рака шейки матки. Дальневосточный медицинский журнал. 2013; 3: 130-4. [Kurunova I.I., Borovskaya T.F., Marochko A.Yu., Bessmertnaya N.G. Epidemiological aspects of cervical cancer. Dal’nevostochnyj medicinskij zhurnal/Far Eastern Medical Journal. 2013; (3): 130-4. (in Russian)]

19. Каприн А.Д., Новикова Е.Г., Трушина О.И., Грецова О.П. Скрининг рака шейки матки – нерешенные проблемы. Исследования и практика в медицине. 2015; 2(1): 36-41. [Kaprin A.D., Novikova E.G., Trushina O.I., Gretsova O.P. Screening for cervical cancer is an unresolved problem. Issledovanija i praktika v medicine/Research and practice in medicine. 2015; 2(1): 36-41. (in Russian)]

20. Клинышкова Т.В., Турчанинов Д.В., Самосудова И.Б. Оценка взаимосвязи степени CIN и возраста женщин. Акушерство и гинекология. 2013; 8: 63-7. [Klinyshkova T.V., Turchaninov D.V., Samosudova I.B. Assessment of the relationship between cervical intraepithelial neoplasia grade and female age. Akusherstvo i ginekologija/Obstetrics and gynecology. 2013(8): 63-67. (in Russian)]

21. Ronco G., Dillner J., Elfström K.M., Tunesi S., Snijders P.J., Arbyn M. et al.; International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014; 383(9916): 524-32.

Received 19.07.2017

Accepted 23.09.2017

About the Authors

Klinyshkova Tatyana Vladimirovna, MD, Full Professor, Professor of the Graduate Education Department of obstetrics and gynecology, Omsk State Medical University, Ministry of Health of Russia. 644043, Russia, Omsk, Lenina str. 12. Tel.: +7620315480. Е-mail: klin_tatyana@mail.ru. ORCID ID: 0000-0002-0544-8184
Turchaninov Denis Vladimirovich, M.D., Full Professor, Head of the Department of Hygiene and Nutrition, Omsk State Medical University, Ministry of Health of Russia.
644043, Russia, Omsk, Lenina str. 12. Tel.: +73812605418. Е-mail: omskgsen@yandex.ru. ORCID ID: 0000-0002-6298-4872
Buyan Mariya Sergeevna, obstetrician-gynecologist, head of women’s consultation, City Polyclinic Eight.
644052, Russia, Omsk, Bagrationa str. 10. Tel.: +7620302221. E-mail: mam_agata@mail.ru. ORCID ID: 0000-0002-8413-3809

For citations: Klinyshkova T.V., Turchaninov D.V., Buyan M.S.
Cervical cancer in the Omsk Region: epidemiological aspects.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2018; (3): 102-8. (in Russian)
https://dx.doi.org/10.18565/aig.2018.3.102-108

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.